SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: luis a. garcia who wrote (1031)4/20/1998 7:18:00 PM
From: agee  Read Replies (1) | Respond to of 1115
 
Spoke to investor relations today ,she said the the stock holders meeting date would be announced some time this week



To: luis a. garcia who wrote (1031)4/22/1998 11:17:00 PM
From: John Zwiener  Read Replies (2) | Respond to of 1115
 
Don't know how valacyclovir relates to lidakol because we don't have the lidakol numbers.

If lidakol is as good as valcyclovir, then lidakol should do fine. No nucleic acid analogs to mess with. No worry about effects on unborn infants or other possible side effects.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News